NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.12
+0.11 (0.55%)
Nov 21, 2024, 4:00 PM EST - Market closed

NAMS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,859920889139-
Market Cap Growth
96.23%3.44%537.58%--
Enterprise Value
1,426501796144-
Last Close Price
20.0111.1710.909.75-
PS Ratio
53.6865.268.66--
PB Ratio
4.873.192.072.46-
P/TBV Ratio
3.953.192.072.46-
P/FCF Ratio
--85.12--
P/OCF Ratio
--83.36--
EV/Sales Ratio
42.4635.567.75--
EV/FCF Ratio
--76.18--
Debt / Equity Ratio
0.000.000.000.00-3.26
Debt / FCF Ratio
--0.01--
Asset Turnover
-0.030.38--
Quick Ratio
10.376.8613.035.810.61
Current Ratio
10.616.9513.265.960.72
Return on Equity (ROE)
-47.37%-49.25%-9.30%-159.01%-
Return on Assets (ROA)
--27.70%-0.81%-55.71%-
Return on Capital (ROIC)
-27.39%-31.82%-0.91%-66.25%-
Earnings Yield
-10.57%-19.24%-2.55%-29.97%-
FCF Yield
-8.23%-15.36%1.17%-21.18%-
Buyback Yield / Dilution
-45.44%-333.20%-72.75%-119.58%-
Total Shareholder Return
-45.44%-333.20%-72.75%-119.58%-
Source: S&P Capital IQ. Standard template. Financial Sources.